Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Epithelial Carcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT01234519
What this trial is testing

A Phase I/II Trial of AEZS-108 in Urothelial Cancer Patients Who Failed Platinum-chemotherapy

Who this might be right for
Urothelial Carcinoma
AEterna Zentaris 12
Very early researchEnded earlyNCT04601428
What this trial is testing

Hepatic IA Therapy in Stage B or Limited Stage C Hepatoma (HCC)

Who this might be right for
Hepatocellular Carcinoma (HCC)
Koo Foundation Sun Yat-Sen Cancer Center 12
Early research (Phase 1)Study completedNCT05226728
What this trial is testing

Pharmacokinetically-guided on the Individualization of Pembrolizumab Administration in the Treatment of Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
Sun Yat-sen University 33
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07489300
What this trial is testing

Benmelstobart in Combination With Anlotinib and Oral Metronomic Cyclophosphamide in the Treatment of Recurrent Epithelial OvariaN, Fallopian Tube, or Primary Peritoneal Cancer

Who this might be right for
Ovarian CancerFallopian Tube CancersPrimary Peritoneal Cancer
Second Affiliated Hospital, Zhejiang University, School of Medicine 40
Large-scale testing (Phase 3)UnknownNCT02611700
What this trial is testing

Nimotuzumab in Combined With Paclitaxel and Cisplatin for Treatment of Metastatic Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Squamous Cell Carcinomas
Biotech Pharmaceutical Co., Ltd. 504
Not applicableLooking for participantsNCT03686709
What this trial is testing

Y90 Radioembolization Dose Delivery and Radiation Exposure Assessment

Who this might be right for
Hepatocellular CarcinomaRadiation Exposure
University of Tennessee 20
Not applicableLooking for participantsNCT06167109
What this trial is testing

NBI Combined With MRI to Guide CTV Optimization in Eccentric Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma by AJCC V8 Stage
Chongqing University Cancer Hospital 60
Not applicableStudy completedNCT05233098
What this trial is testing

TheraSphere Post-Approval Study to Calculate the Radiation-absorbed Dose of Tc-99m MAA.

Who this might be right for
Hepatocellular Carcinoma
Boston Scientific Corporation 6
Testing effectiveness (Phase 2)Study completedNCT02607553
What this trial is testing

Safety and Activity of G-202 in Patients With Clear Cell Renal Cell Carcinoma That Expresses PSMA

Who this might be right for
Clear Cell Renal Cell Carcinoma
GenSpera, Inc. 2
Large-scale testing (Phase 3)UnknownNCT05056337
What this trial is testing

Toripalimab in Combination With Lenvatinib and TACE for Conversion Therapy in Patients With Potentially Resectable HCC

Who this might be right for
Hepatocellular Carcinoma
Shanghai Zhongshan Hospital 220
Not applicableWithdrawnNCT01847495
What this trial is testing

Evaluation of Low-dose Irinotecan and Cyberknife® SBRT to Treat Colorectal Cancer With Limited Liver Metastasis

Who this might be right for
Colorectal Cancer
Wake Forest University Health Sciences
Early research (Phase 1)Study completedNCT01379339
What this trial is testing

Cabazitaxel - PF Induction Chemotherapy

Who this might be right for
Squamous Cell Carcinoma of the Head and Neck
Krzysztof Misiukiewicz 40
Testing effectiveness (Phase 2)Study completedNCT00001239
What this trial is testing

Combination Chemotherapy (FLAC) Combined With Granulocyte-Macrophage Colony Stimulating Factor in Locally Advanced and Metastatic Breast Cancer

Who this might be right for
Breast CancerBreast Neoplasms
National Cancer Institute (NCI) 100
Not applicableStudy completedNCT01487057
What this trial is testing

Lipid Metabolic Status in Thyroid Carcinoma

Who this might be right for
Thyroid CarcinomaDyslipidemiasRisk Reduction Behavior+1 more
Prof. Dr. I. Chiricuta Institute of Oncology 52
Testing effectiveness (Phase 2)WithdrawnNCT02649530
What this trial is testing

A Phase II Trial Evaluating WNT974 in Patients With Metastatic Head and Neck Squamous Cell Carcinoma

Who this might be right for
Squamous Cell Carcinoma, Head And Neck
University of Michigan Rogel Cancer Center
Testing effectiveness (Phase 2)Study completedNCT01725165
What this trial is testing

Surgery and/or Radiation Therapy or Standard Therapy and/or Clinical Observation in Treating Patients With Previously Treated Stage IV Non-small Cell Lung Cancer

Who this might be right for
Recurrent Lung Non-Small Cell CarcinomaStage IV Non-Small Cell Lung Cancer AJCC v7
M.D. Anderson Cancer Center 85
Testing effectiveness (Phase 2)Ended earlyNCT00549328
What this trial is testing

Monotherapy Pazopanib in Subjects With Advanced Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer, Non-Small Cell
GlaxoSmithKline 14
Early research (Phase 1)UnknownNCT01456065
What this trial is testing

Safety of Active Immunotherapy in Subjects With Ovarian Cancer

Who this might be right for
Ovarian Epithelial Cancer
Life Research Technologies GmbH 15
Early research (Phase 1)Ended earlyNCT03634267
What this trial is testing

MRI-Guided Brachytherapy in Treating Participants With HPV-Associated Stage IB2-IVA Cervical or Stage II-IVA Vaginal Cancer

Who this might be right for
Human Papillomavirus-Related CarcinomaHuman Papillomavirus-Related Cervical CarcinomaStage IB2 Cervical Cancer AJCC v8+14 more
M.D. Anderson Cancer Center 26
Not applicableLooking for participantsNCT02682667
What this trial is testing

Biospecimen Procurement for Center for Immuno-Oncology Immunotherapy Protocols

Who this might be right for
Multiple MyelomaLymphoma, Non-HodgkinLeukemia-Lymphoma, Adult T-Cell+2 more
National Cancer Institute (NCI) 500
Next Page